ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,347Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 81

$1.51M Total Retail Price of All Prescriptions

Rank: 9 out of 81

475 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 475 patients filled at least one prescription for a schedule two drug, compared to an average of 14%.

Schedule Three
Controlled Substances

20% of this provider’s 475 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 26,135 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

60 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
WARFARIN SODIUM 1,207 1,126 1 9
LEVOTHYROXINE SODIUM 924 877 2 3
SIMVASTATIN 867 783 3 5
OMEPRAZOLE 826 793 4 4
LISINOPRIL 797 723 5 2
FUROSEMIDE 734 696 6 1
HYDROCODONE-ACETAMINOPHEN 703 621 S3 7 12
DONEPEZIL HCL 632 630 8 8
MIRTAZAPINE 608 554 9 14
AMLODIPINE BESYLATE 530 504 10 6
CITALOPRAM HBR 524 493 11 10
METOPROLOL TARTRATE 458 452 12 7
POTASSIUM CHLORIDE 431 416 13 16
GABAPENTIN 391 372 14 13
SERTRALINE HCL 390 347 15 19
CYMBALTA 380 342 16 30
NAMENDA 365 364 17 11
ATORVASTATIN CALCIUM 320 298 18 18
OXYCODONE-ACETAMINOPHEN 311 242 S2 19 24
CARVEDILOL 311 279 19 27
OXYBUTYNIN CHLORIDE ER 307 307 21 53
LANTUS 301 237 22 23
FLUTICASONE PROPIONATE 286 264 23 58
RISPERIDONE 281 256 24 26
QUETIAPINE FUMARATE 276 238 25 31
DIVALPROEX SODIUM 269 236 26 25
ALLOPURINOL 265 265 27 41
ALENDRONATE SODIUM 264 262 28 32
CARBIDOPA-LEVODOPA 239 222 29 62
CLOPIDOGREL 233 226 30 37
TAMSULOSIN HCL 232 200 31 29
METFORMIN HCL 227 227 32 15
ATENOLOL 227 214 32 28
NEXIUM 218 170 34 66
FAMOTIDINE 208 199 35 60
DIGOXIN 207 207 36 49
LIDODERM 203 200 37 43
NITROFURANTOIN MONO-MACRO 198 198 38 87
GLIPIZIDE 194 174 39 46
OLANZAPINE 188 186 40 55
LANTUS SOLOSTAR 183 183 41 69
LOSARTAN POTASSIUM 174 172 42 34
HYDROCHLOROTHIAZIDE 172 160 43 21
TRAMADOL HCL 160 160 44 17
VANCOMYCIN HCL 159 126 45 196
ESCITALOPRAM OXALATE 157 157 46 42
PANTOPRAZOLE SODIUM 145 140 47 72
LEVETIRACETAM 142 101 48 48
PREDNISONE 141 134 49 40
NYSTATIN 139 134 50 90
PLAVIX 139 127 50 63
HYDRALAZINE HCL 135 110 52 52
NOVOLIN R 134 90 53 91
VENLAFAXINE HCL ER 134 125 53 78
LIDOCAINE HCL 131 114 55 185
CLONIDINE HCL 126 105 56 59
METOPROLOL SUCCINATE 124 124 57 22
TRAZODONE HCL 124 113 57 20
PRAVASTATIN SODIUM 123 100 59 33
CEPHALEXIN 120 117 60 73
LYRICA 113 96 61 75
ISOSORBIDE MONONITRATE ER 113 101 61 38
METRONIDAZOLE 111 95 63 181
NYSTOP 111 109 63 96
CIPROFLOXACIN HCL 105 101 65 64
LEVOFLOXACIN 103 102 66 121
ADVAIR DISKUS 103 99 66 67
ROPINIROLE HCL 101 101 68 108
CEFTRIAXONE 101 95 68 138
FENOFIBRATE 101 88 68 133
AMOX TR-POTASSIUM CLAVULANATE 99 89 71 104
LACTULOSE 96 60 72 80
IPRATROPIUM-ALBUTEROL 96 86 72 57
TORSEMIDE 95 95 74 151
DIOVAN 95 95 74 50
LOPERAMIDE 94 91 76 168
KLOR-CON M20 93 93 77 39
NOVOLOG 91 81 78 51
ALBUTEROL SULFATE 91 84 78 56
DILTIAZEM 24HR CD 91 91 78 83
PAROXETINE HCL 91 91 78 101
EXELON 88 88 82 47
SEROQUEL 88 76 82 79
BUSPIRONE HCL 85 85 84 117
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 54 85 77
BACLOFEN 82 56 86 86
MELOXICAM 80 80 87 68
RANITIDINE HCL 79 76 88 61
MORPHINE SULFATE ER 78 76 S2 89 82
NITROFURANTOIN 73 73 90 147
FINASTERIDE 72 72 91 93
COLCRYS 71 69 92 221
ZOLPIDEM TARTRATE 70 62 93 45
ZETIA 69 45 94 178
LEXAPRO 66 66 95 110
SPIRONOLACTONE 64 64 96 70
KLOR-CON M10 63 62 97 94
FENTANYL 63 63 S2 97 65
AMOXICILLIN 61 58 99 155
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 60 100 99
OXYCONTIN 60 51 S2 100 71
PROMETHAZINE HCL 60 44 R 100 74
SPIRIVA 59 55 103 76
METOCLOPRAMIDE HCL 58 13 104 118
TRIMETHOPRIM 58 58 104 326
PHENYTOIN SODIUM EXTENDED 56 39 106 111
CLOZAPINE 56 32 106 113
GENERLAC 55 55 108 103
LOVASTATIN 54 54 109 88
OXYBUTYNIN CHLORIDE 53 53 110 170
TRAVATAN Z 53 45 110 102
SUCRALFATE 53 53 110 235
DOXAZOSIN MESYLATE 52 50 113 164
OXYCODONE HCL-ACETAMINOPHEN 52 52 S2 113 159
METOLAZONE 51 46 115 166
CYCLOBENZAPRINE HCL 51 42 R 115 173
CRESTOR 50 47 117 81
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.